, Tracking Stock Market Picks
Enter Symbol:
Rating: ABAX
Hold $53

Abaxis, Inc. (NASDAQ: ABAX) downgraded to Hold with price target $53 by Canaccord Genuity

Thursday,  Nov 12, 2015  8:25 AM ET by Betsy O'Brien Harrison

Canaccord Genuity downgraded Abaxis, Inc. (NASDAQ: ABAX) to Hold with price target
$53. Previously Canaccord Genuity downgraded to Abaxis, Inc. (NASDAQ: ABAX) to Buy with price target $64 on 11/25/2014, when the stock price was $57.15.

Abaxis, Inc. develops, manufactures and markets portable blood analysis systems for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The Company's primary product is a system consisting of a compact 6.9 kilogram analyzer and a series of single-use plastic discs called reagent discs containing all the chemicals required to perform a panel of up to 12 tests. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma using either venous or fingerstick samples.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy